The tobacco industry has unfortunately provided a detailed road map for marijuana: deny addiction potential, downplay adverse health effects, create as large a market as possible, and protect it through lobbying, campaign contributions, and other advocacy efforts.
No takes yet. Share an insight, caveat, or question.
Richter et al. (2014) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: